Parkinson's Disease
Neurocrine Biosciences--enrolling
A prospective, open-label, observational study of adult patients with Parkinson's disease with motor fluctuations (PDwMF)who are initiating treatment with ONGENTYS (opicapone)
AbbVie--enrolling
A Prospective Observational Study to evaluate the clinical outcomes and burden of disease of PD patients with motor fluctuations not adequately controlled by current PD medications
A prospective, open-label, observational study of adult patients with Parkinson's disease with motor fluctuations (PDwMF)who are initiating treatment with ONGENTYS (opicapone)
AbbVie--enrolling
A Prospective Observational Study to evaluate the clinical outcomes and burden of disease of PD patients with motor fluctuations not adequately controlled by current PD medications
